Najibi Sasan, Bush Ruth L, Terramani Thomas T, Chaikof Elliot L, Gunnoud Annette B, Lumsden Alan B, Weiss Victor J
Division of Vascular Surgery, Joseph B. Whitehead Department of Surgery, Emory University School of Medicine and Emory University Hospital, Atlanta, GA 30322, USA.
J Surg Res. 2002 Jul;106(1):15-9. doi: 10.1006/jsre.2002.6389.
The traditional repair of hemodialysis graft pseudoaneurysms has been to surgically replace that segment of involved PTFE graft material or autogenous vein. We report a novel approach to these lesions, employing a covered stent (Wallgraft) for exclusion of arteriovenous graft (AVG) and arteriovenous fistula (AVF) pseudoaneurysms.
Ten patients with AVG or AVF pseudoaneurysms were treated endoluminally by covered stent exclusion. Wallgraft implantations were performed in the operating room with interventional capabilities under local anesthesia through a percutaneous access. Follow-up included physical examination at 2 weeks and duplex ultrasound of AVG/ AVF at 6 months after surgery.
Ten patients with pseudoaneurysmal degeneration of their AVG/AVF were identified. The mean diameter of the pseudoaneurysmal segment was 3 cm (range, 1.5-5 cm). Immediately following covered stent implantation all the patients had palpable pulses in the pseudoaneurysms despite adequate coverage by angiography. At the 2-week follow-up visit all had lost the palpable pseudoaneurysm pulsation while the AVGs remained functional in nine patients. One patient had early thrombosis of the AVG. The follow-up duplex scans at 6 months showed complete exclusion of the pseudoaneurysms in seven patients. Two patients had thrombosis of their dialysis access, at 3 weeks (n = 1) and 3 months (n = 1) post-implantation.
Endovascular covered stent exclusion of AV dialysis access pseudoaneurysms is safe and technically feasible in eliminating flow through dialysis access pseudoaneurysms and represents a novel and simple approach to this common problem, prolonging the functional life of the access site.
传统的血液透析移植物假性动脉瘤修复方法是手术更换受累的聚四氟乙烯(PTFE)移植物材料段或自体静脉。我们报告了一种针对这些病变的新方法,即采用覆膜支架(Wallgraft)来封堵动静脉移植物(AVG)和动静脉内瘘(AVF)假性动脉瘤。
10例AVG或AVF假性动脉瘤患者接受了覆膜支架封堵的腔内治疗。Wallgraft植入在手术室进行,在局部麻醉下通过经皮穿刺途径,利用介入设备完成。随访包括术后2周的体格检查以及术后6个月对AVG/AVF的双功超声检查。
确诊10例AVG/AVF发生假性动脉瘤退变的患者。假性动脉瘤段的平均直径为3 cm(范围1.5 - 5 cm)。覆膜支架植入后,尽管血管造影显示封堵充分,但所有患者的假性动脉瘤处仍可触及搏动。在术后2周的随访中,所有患者的假性动脉瘤搏动均消失,9例患者的AVG仍保持功能。1例患者的AVG发生早期血栓形成。术后6个月的随访双功超声检查显示,7例患者的假性动脉瘤被完全封堵。2例患者分别在植入后3周(1例)和3个月(1例)出现透析通路血栓形成。
血管腔内覆膜支架封堵AV透析通路假性动脉瘤在消除透析通路假性动脉瘤内的血流方面是安全且技术可行的,代表了一种针对这一常见问题的新颖且简单的方法,可延长通路部位的功能寿命。